B. Ganidagli Et Al. , "The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients," CLINICAL NEPHROLOGY , vol.91, no.1, pp.9-16, 2019
Ganidagli, B. Et Al. 2019. The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients. CLINICAL NEPHROLOGY , vol.91, no.1 , 9-16.
Ganidagli, B., Nacar, H., Yildiz, Y. S., Dagli, H., Erken, E., Altunoren, O., ... Gungor, O.(2019). The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients. CLINICAL NEPHROLOGY , vol.91, no.1, 9-16.
Ganidagli, Berivan Et Al. "The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients," CLINICAL NEPHROLOGY , vol.91, no.1, 9-16, 2019
Ganidagli, Berivan Et Al. "The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients." CLINICAL NEPHROLOGY , vol.91, no.1, pp.9-16, 2019
Ganidagli, B. Et Al. (2019) . "The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients." CLINICAL NEPHROLOGY , vol.91, no.1, pp.9-16.
@article{article, author={Berivan Ganidagli Et Al. }, title={The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients}, journal={CLINICAL NEPHROLOGY}, year=2019, pages={9-16} }